ANTH

Anthera Pharmaceuticals, Inc.
ANTH

Overview Fund Activity
Delisted

ANTH was delisted on the 27th of June, 2018.

Back to rankings

72 hedge funds and large institutions have $67M invested in Anthera Pharmaceuticals, Inc. in 2016 Q3 according to their latest regulatory filings, with 5 funds opening new positions, 24 increasing their positions, 23 reducing their positions, and 7 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
72
Holders Change
-2
Holders Change %
-2.7%
% of All Funds
1.92%
Holding in Top 10
1
Holding in Top 10 Change
-2
Holding in Top 10 Change %
-66.67%
% of All Funds
0.03%
New
5
Increased
24
Reduced
23
Closed
7
Calls
$738K
Puts
$502K
Net Calls
+$236K
Net Calls Change
+$329K

Top Buyers

1
DADC
D.A. Davidson & Co
Montana
+$805K
2
Fidelity Investments
Fidelity Investments
Massachusetts
+$519K
3
UBS Group
UBS Group
Switzerland
+$360K
4
BFA
BlackRock Fund Advisors
California
+$259K
5
Vanguard Group
Vanguard Group
Pennsylvania
+$239K

Top Sellers

1
SCM
Sio Capital Management
New York
-$5.15M
2
BCM
Bridgeway Capital Management
Texas
-$463K
3
State Street
State Street
Massachusetts
-$278K
4
Jacobs Levy Equity Management
Jacobs Levy Equity Management
New Jersey
-$254K
5
SGAM
Smith Group Asset Management
Texas
-$152K
Name Holding Trade Value Shares
Change 		Shares
Change %
Dimensional Fund Advisors
76
Dimensional Fund Advisors
Texas
– -$89K -3,595 Closed
BFM
77
Boothbay Fund Management
New York
– -$49K -1,995 Closed
JPMorgan Chase & Co
78
JPMorgan Chase & Co
New York
– -$7K -266 Closed
1 2 3
4